These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 30341800)

  • 1. Efficacy and safety of etanercept for postoperative pyoderma gangrenosum after infliximab serum sickness.
    Ariane M; Bouaziz JD; de Masson A; Jachiet M; Bagot M; Lepelletier C
    Dermatol Ther; 2019 Jan; 32(1):e12774. PubMed ID: 30341800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab for peristomal pyoderma gangrenosum.
    Mimouni D; Anhalt GJ; Kouba DJ; Nousari HC
    Br J Dermatol; 2003 Apr; 148(4):813-6. PubMed ID: 12752145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical uveitis and pyoderma gangrenosum in a patient with psoriatic arthritis under infliximab treatment.
    Fujimoto N; Yamasaki Y; Watanabe R
    J Dtsch Dermatol Ges; 2018 Sep; 16(9):1139-1140. PubMed ID: 30129996
    [No Abstract]   [Full Text] [Related]  

  • 5. Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn disease.
    Batres LA; Mamula P; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2002 May; 34(5):558-60. PubMed ID: 12050585
    [No Abstract]   [Full Text] [Related]  

  • 6. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
    Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
    Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of postoperative pyoderma gangrenosum with cyclosporin.
    Schöfer H; Baur S
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):148-51. PubMed ID: 12046819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infliximab for a girl with refractory pyoderma gangrenosum].
    Nozawa T; Hara R; Kinoshita J; Sano F; Miyamae T; Imagawa T; Mori M; Hirokado M; Takahashi K; Inayama Y; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):454-9. PubMed ID: 19122376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyoderma gangrenosum in an infant: A case report and review of the literature.
    Crouse L; McShane D; Morrell DS; Wu EY
    Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyoderma gangrenosum arising in a breast reduction scar: seven years post-procedure.
    Segaran A; Mohammad M; Sterling JC; Malata CM
    J Plast Reconstr Aesthet Surg; 2013 Dec; 66(12):e370-2. PubMed ID: 23759719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-surgical pyoderma gangrenosum of the breast: needs for early diagnosis and right therapy.
    Guaitoli G; Piacentini F; Omarini C; Andreotti A; Palma E; Papi S; De Pietri C; Conti A; Cascinu S; Tazzioli G
    Breast Cancer; 2019 Jul; 26(4):520-523. PubMed ID: 30564995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoderma Gangrenosum as Differential Diagnosis to Post-Operative Infection after Breast Plastic Surgery.
    Coste V; Klopfenstein T; Andreoletti JB; Clerc J; Noel AC; Gendrin V; Ducournau A; Zayet S
    Surg Infect (Larchmt); 2022 Aug; 23(6):604-606. PubMed ID: 35649209
    [No Abstract]   [Full Text] [Related]  

  • 14. Unusual cause of breast wound: postoperative pyoderma gangrenosum.
    Abtahi-Naeini B; Bagheri F; Pourazizi M; Forozeshfard M; Saffaei A
    Int Wound J; 2017 Feb; 14(1):285-287. PubMed ID: 27444684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review.
    Afifi L; Sanchez IM; Wallace MM; Braswell SF; Ortega-Loayza AG; Shinkai K
    J Am Acad Dermatol; 2018 Jun; 78(6):1195-1204.e1. PubMed ID: 29288099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatologic manifestations of Crohn disease in children: response to infliximab.
    Kugathasan S; Miranda A; Nocton J; Drolet BA; Raasch C; Binion DG
    J Pediatr Gastroenterol Nutr; 2003 Aug; 37(2):150-4. PubMed ID: 12883301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pyoderma gangrenosum with infliximab in Crohn's disease.
    Sapienza MS; Cohen S; Dimarino AJ
    Dig Dis Sci; 2004 Sep; 49(9):1454-7. PubMed ID: 15481318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
    Vacas AS; Torre AC; Bollea-Garlatti ML; Warley F; Galimberti RL
    Int J Dermatol; 2017 Apr; 56(4):386-391. PubMed ID: 28295267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyoderma gangrenosum following breast reduction: treatment with topical tacrolimus and steroids.
    Doren EL; Aya-ay ML
    Aesthet Surg J; 2014 Mar; 34(3):394-9. PubMed ID: 24448967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.